Skip to main content
Login
Contact
Subscribe
Search form
Search
Malvern Daily Record
Click for weather forecast
Home
Forms
Delivery Concerns
News
Sports
University of Arkansas
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Local Guide
Local Ads
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Cellectar Biosc
(NQ:
CLRB
)
1.410
USD
+0.070 (+5.22%)
Official Closing Price
/ Updated:
7:57 PM EDT, Jul 2, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
1,096,700
Open
1.380
Bid (Size)
1.420 (7)
Ask (Size)
1.430 (1)
Prev. Close
1.340
Today's Range
1.380 - 1.480
52wk Range
1.010 - 3.330
Shares Outstanding
17,708,558
Dividend Yield
N/A
Performance
YTD
-43.37%
-43.37%
1 Month
+23.68%
+23.68%
3 Month
+8.46%
+8.46%
6 Month
-42.68%
-42.68%
1 Year
-32.86%
-32.86%
Top News
More News
Cellectar Appoints Dr. John Friend as Chief Medical Officer
July 01, 2020
from
GlobeNewswire News Releases
Cellectar to be Granted EU Patent for Phospholipid Ether (PLE) Analogs as Cancer-Targeting Drug Vehicles
June 11, 2020
Covers composition of matter and method of use into 2036 for proprietary PLE analogs in combination with various small molecule chemotherapeutics
Read More
from
GlobeNewswire News Releases
More News
Read More
Cellectar Biosciences Announces Closing of $20 Million Underwritten Public Offering
June 05, 2020
from
GlobeNewswire News Releases
Cellectar Biosciences Announces Pricing of $20 Million Underwritten Public Offering
June 03, 2020
from
GlobeNewswire News Releases
NetworkNewsBreaks – Cellectar Biosciences, Inc. (NASDAQ: CLRB) Secures $20.0M in Underwritten Public Offering
June 10, 2020
from
InvestorBrandNetwork
Cellectar Granted SME Status by the European Medicines Agency
June 01, 2020
from
GlobeNewswire News Releases
Why Cellectar Biosciences Stock Is Trading Higher Today
July 01, 2020
category
Market News
,
why it's moving
,
Penny Stocks
, and 5 more.
from
Benzinga
Cellectar Receives FDA Fast Track Designation for CLR 131 in Lymphoplasmacytic Lymphoma/Waldenstrom’s Macroglobulinemia
May 26, 2020
from
GlobeNewswire News Releases
Stocks That Hit 52-Week Lows On Wednesday
June 03, 2020
category
Benzinga
,
Intraday Update
,
52/Week Lows
, and 10 more.
from
Benzinga
P/E Ratio Insights for Cellectar Biosciences
May 26, 2020
category
Penny Stocks
,
Market News
,
Intraday Update
, and 7 more.
from
Benzinga
34 Stocks Moving in Wednesday's Pre-Market Session
June 10, 2020
category
ZI
,
Movers
,
Top Gainers
, and 43 more.
from
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
